Literature DB >> 20622898

p53 isoforms gain functions.

V Olivares-Illana1, R Fåhraeus.   

Abstract

Many different cell stress pathways converge on p53 to induce a number of distinct cell biological responses such as G1 or G2 arrest, senescence or apoptosis. One of the outstanding questions with regard to p53 is how the cells can differentiate between different stresses so that p53 activation leads to the correct response. It has been known for some time that the p53 gene expresses isoforms that carry unique domains and properties, and more recent works have started to reveal some of their functions. The alternative mRNA translation product p53/47, which lacks the first 40 codons, including the first of p53's two trans-activation domains, is being linked to endoplasmic reticulum stress and the unfolded protein response to which it causes a specific G2 arrest. On the other hand, p53 itself induces G1 arrest and has no effect on the G2. The two isoforms Δ133p53, which lacks the first 133 amino acids, and p53β, which carries an alternative C-terminus, are derived from alternative promoter usage or splicing, respectively, and are together implied in controlling cellular senescence. Hence, through different mechanisms of gene expression control, alternative levels of p53 isoforms help the cell to differentiate between p53 activation and the response to diverse stresses. This holds promise to a better understanding of how upstream and downstream p53 pathways have evolved relative to specific p53 domains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20622898     DOI: 10.1038/onc.2010.266

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Authors:  Annemarie Koch; Jiri Hatina; Harald Rieder; Hans-Helge Seifert; Wolfgang Huckenbeck; Frank Jankowiak; Andrea R Florl; Robert Stoehr; Wolfgang A Schulz
Journal:  Cell Oncol (Dordr)       Date:  2012-06-06       Impact factor: 6.730

2.  Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.

Authors:  Petar Stefanov Kovachev; Debapriya Banerjee; Luciana Pereira Rangel; Jonny Eriksson; Murilo M Pedrote; Mafalda Maria D C Martins-Dinis; Katarina Edwards; Yraima Cordeiro; Jerson L Silva; Suparna Sanyal
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

Review 3.  Senescence regulation by the p53 protein family.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Methods Mol Biol       Date:  2013

Review 4.  Modelling the p53/p66Shc Aging Pathway in the Shortest Living Vertebrate Nothobranchius Furzeri.

Authors:  Chiara Priami; Giulia De Michele; Franco Cotelli; Alessandro Cellerino; Marco Giorgio; Pier Giuseppe Pelicci; Enrica Migliaccio
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

5.  p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction.

Authors:  Ixaura Medina-Medina; Mayra Martínez-Sánchez; Jesús Hernández-Monge; Robin Fahraeus; Petr Muller; Vanesa Olivares-Illana
Journal:  Protein Sci       Date:  2018-03-25       Impact factor: 6.725

6.  Targeted RNA sequencing reveals the deep complexity of the human transcriptome.

Authors:  Tim R Mercer; Daniel J Gerhardt; Marcel E Dinger; Joanna Crawford; Cole Trapnell; Jeffrey A Jeddeloh; John S Mattick; John L Rinn
Journal:  Nat Biotechnol       Date:  2011-11-13       Impact factor: 54.908

Review 7.  Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.

Authors:  Alexander H Stegh
Journal:  Expert Opin Ther Targets       Date:  2012-01-12       Impact factor: 6.902

Review 8.  Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Int J Cancer       Date:  2016-02-08       Impact factor: 7.396

9.  Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers.

Authors:  M Tumiati; P M Munne; H Edgren; S Eldfors; A Hemmes; S G Kuznetsov
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

10.  Post-translational regulation of p53 function through 20S proteasome-mediated cleavage.

Authors:  Hilla Solomon; Bastian Bräuning; Irit Fainer; Gili Ben-Nissan; Stav Rabani; Naomi Goldfinger; Oren Moscovitz; Zippora Shakked; Varda Rotter; Michal Sharon
Journal:  Cell Death Differ       Date:  2017-09-08       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.